Chemotherapeutic Activity of Imidazolium-Supported Pd(II) <i>o</i>-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells

Chemotherapeutic Activity of Imidazolium-Supported Pd(II) <i>o</i>-Vanillylidene Diaminocyclohexane Complexes Immobilized in Nanolipid as Inhibitors for HER2/neu and FGFR2/FGF2 Axis Overexpression in Breast Cancer Cells

Two bis-(imidazolium–vanillylidene)-(<i>R</i>,<i>R</i>)-diaminocyclohexane ligands (H<sub>2</sub>(VAN)<sub>2</sub>dach, H<sub>2</sub>L<sub>1,2</sub>) and their Pd(II) complexes (PdL<sub>1</sub> and PdL<sub>2<...

Full description

Bibliographic Details
Main Authors: Aeshah A. Awaji, Moustafa A. Rizk, Raiedhah A. Alsaiari, Norah F. Alqahtani, Fatima A. Al-Qadri, Ali S. Alkorbi, Hani S. Hafez, Reda F. M. Elshaarawy
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pharmaceuticals
Subjects:
imidazolium–vanillylidene ligands
Pd(II) complexes-enacapsulated nanolipids
cytotoxicity
HER2/neu
FGFR2/FGF2
apoptosis
Online Access:https://www.mdpi.com/1424-8247/16/12/1711

Internet

https://www.mdpi.com/1424-8247/16/12/1711

Similar Items